These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19028613)

  • 1. Optical imaging of the breast.
    van de Ven SM; Elias SG; van den Bosch MA; Luijten P; Mali WP
    Cancer Imaging; 2008 Nov; 8(1):206-15. PubMed ID: 19028613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developments toward diagnostic breast cancer imaging using near-infrared optical measurements and fluorescent contrast agents.
    Hawrysz DJ; Sevick-Muraca EM
    Neoplasia; 2000; 2(5):388-417. PubMed ID: 11191107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Administration and Detection of a Near-Infrared Molecular Imaging Agent in an Orthotopic Mouse Model for Breast Cancer Screening.
    Bhatnagar S; Verma KD; Hu Y; Khera E; Priluck A; Smith DE; Thurber GM
    Mol Pharm; 2018 May; 15(5):1746-1754. PubMed ID: 29696981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contrast media for optical mammography].
    Riefke B; Licha K; Semmler W
    Radiologe; 1997 Sep; 37(9):749-55. PubMed ID: 9424621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypyrrole nanoparticles: a potential optical coherence tomography contrast agent for cancer imaging.
    Au KM; Lu Z; Matcher SJ; Armes SP
    Adv Mater; 2011 Dec; 23(48):5792-5. PubMed ID: 22102372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Functional and molecular imaging of breast tumors].
    Pinker K; Brader P; Karanikas G; El-Rabadi K; Bogner W; Gruber S; Reisegger M; Trattnig S; Helbich TH
    Radiologe; 2010 Nov; 50(11):1030-8. PubMed ID: 20842342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-infrared fluorescence optical imaging and tomography.
    Gurfinkel M; Ke S; Wen X; Li C; Sevick-Muraca EM
    Dis Markers; 2003-2004; 19(2-3):107-21. PubMed ID: 15096708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing physiology and molecular function using optical imaging: applications to breast cancer.
    Ntziachristos V; Chance B
    Breast Cancer Res; 2001; 3(1):41-6. PubMed ID: 11250744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the future of diffuse optical imaging technologies for breast cancer management.
    Tromberg BJ; Pogue BW; Paulsen KD; Yodh AG; Boas DA; Cerussi AE
    Med Phys; 2008 Jun; 35(6):2443-51. PubMed ID: 18649477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical Imaging of the Breast: Basic Principles and Clinical Applications.
    Di Leo G; Trimboli RM; Sella T; Sardanelli F
    AJR Am J Roentgenol; 2017 Jul; 209(1):230-238. PubMed ID: 28379746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical imaging in breast cancer diagnosis: the next evolution.
    Herranz M; Ruibal A
    J Oncol; 2012; 2012():863747. PubMed ID: 23304141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near-infrared imaging of breast cancer using optical contrast agents.
    Poellinger A
    J Biophotonics; 2012 Nov; 5(11-12):815-26. PubMed ID: 23132668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional calcium phosphate nano-contrast agent for combined nuclear, magnetic and near-infrared in vivo imaging.
    Ashokan A; Gowd GS; Somasundaram VH; Bhupathi A; Peethambaran R; Unni AK; Palaniswamy S; Nair SV; Koyakutty M
    Biomaterials; 2013 Sep; 34(29):7143-57. PubMed ID: 23791501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical detection of breast cancer by spectrum method].
    Gao TX; Fan XF; Xuan LX; Zhang BN; Li X; Bai J
    Guang Pu Xue Yu Guang Pu Fen Xi; 2008 Nov; 28(11):2531-5. PubMed ID: 19271483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Near-infrared optical mammography for breast cancer detection with intrinsic contrast.
    Fantini S; Sassaroli A
    Ann Biomed Eng; 2012 Feb; 40(2):398-407. PubMed ID: 21971964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective pilot clinical trial evaluating the utility of a dynamic near-infrared imaging device for characterizing suspicious breast lesions.
    Xu RX; Young DC; Mao JJ; Povoski SP
    Breast Cancer Res; 2007; 9(6):R88. PubMed ID: 18088411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of NIR dyes in cancer targeting and imaging.
    Luo S; Zhang E; Su Y; Cheng T; Shi C
    Biomaterials; 2011 Oct; 32(29):7127-38. PubMed ID: 21724249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonnegative matrix factorization: a blind spectra separation method for in vivo fluorescent optical imaging.
    Montcuquet AS; Hervé L; Navarro F; Dinten JM; Mars JI
    J Biomed Opt; 2010; 15(5):056009. PubMed ID: 21054103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of optical breast imaging and spectroscopy.
    Grosenick D; Rinneberg H; Cubeddu R; Taroni P
    J Biomed Opt; 2016 Sep; 21(9):091311. PubMed ID: 27403837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Near-infrared fluorescence imaging for the prevention and management of breast cancer-related lymphedema: A systematic review.
    Abbaci M; Conversano A; De Leeuw F; Laplace-Builhé C; Mazouni C
    Eur J Surg Oncol; 2019 Oct; 45(10):1778-1786. PubMed ID: 31221460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.